Ypsomed and Mediq are completing the sale of DiaExpert. Ypsomed and Mediq had announced the agreement on the sale of DiaExpert on 28 October 2022.
Oramed Pharmaceuticals has announced that it has received a new patent for its oral diabetes treatment. The patent covers oral pharmaceutical compositions comprising insulin in
The US Food and Drug Administration has approved a new medication for Type 2 diabetes called Brenzavvy. This belongs to a class of drugs known
A small potential increased risk of retinopathy worsening after one year for those with Type 2 diabetes following injections of the GLP-1 agonist semaglutide does
Dexcom has announced that it has appointed Teri Lawver to its newly created role of chief commercial officer (CCO). Lawver’s position oversees the global commercial
The self-management of diabetes can be tiring and tough on mental health but a key benefit of peer support is access to help from peers
Embecta has added an all-in-one, push-button fingerstick glucose reader to its portfolio. Launched this past April as a spinout from medtech giant BD, Embecta has
ABCD (Diabetes Care) Ltd have announced that the new Chair of ABCD will be Professor Ketan Dhatariya, who will take over from Dr Dipesh Patel
New results from a first-of-its-kind survey by Abbott has identified a clear disconnect between the perceptions of the British public and those living with diabetes
Recruitment has opened for a trial screening programme for Type 1 diabetes that will identify children at high risk of developing the condition, laying the
